Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells.

A discontinuous pattern of LOH at chromosome 3p has been reported in 87% of primary breast cancers. Despite the identification of several tumor suppressor genes in this region, there has yet to be a detailed analysis of noncoding RNAs including miRNAs in this region. In this study, we identified 16 aberrant miRNAs in this region and determined several that are frequently lost or amplified in breast cancer. miR-128-2 was the most commonly deleted miRNA. Embedded in the intron of the ARPP21 gene at chromosome 3p22.3, miR-128-2 was frequently downregulated along with ARPP21 in breast cancer, where it was negatively associated with clinicopathologic characteristics and survival outcome. Forced expression of miR-128 impeded several oncogenic traits of mammary carcinoma cells, whereas depleting miR-128-2 expression was sufficient for oncogenic transformation and stem cell-like behaviors in immortalized nontumorigenic mammary epithelial cells, both in vitro and in vivo. miR-128-2 silencing enabled transforming capacity partly by derepressing a cohort of direct targets (BMI1, CSF1, KLF4, LIN28A, NANOG, and SNAIL), which together acted to stimulate the PI3K/AKT and STAT3 signaling pathways. We also found that miR-128-2 was directly downregulated by SNAIL and repressed by TGF-β signaling, adding 2 additional negative feedback loops to this network. In summary, we have identified a novel TGF-β/SNAIL/miR-128 axis that provides a new avenue to understand the basis for oncogenic transformation of mammary epithelial cells.

[1]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[2]  R. Young,et al.  Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.

[3]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[4]  S. Yamanaka,et al.  Intracellular signaling pathways regulating pluripotency of embryonic stem cells. , 2006, Current stem cell research & therapy.

[5]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[6]  Gang Pei,et al.  More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells , 2009, Cell Research.

[7]  J. Datta,et al.  IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway , 2011, Molecular Cancer Research.

[8]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[9]  M. Mitchell,et al.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. , 2008, Endocrinology.

[10]  N. Joste,et al.  Breast Field Cancerization: Isolation and Comparison of Telomerase-Expressing Cells in Tumor and Tumor Adjacent, Histologically Normal Breast Tissue , 2011, Molecular Cancer Research.

[11]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[12]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[13]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Yajun Chen,et al.  MicroRNA-191 targets N-deacetylase/N-sulfotransferase 1 and promotes cell growth in human gastric carcinoma cell line MGC803. , 2011, Acta biochimica et biophysica Sinica.

[15]  M. Stratton.  Exploring the Genomes of Cancer Cells: Progress and Promise , 2011, Science.

[16]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[17]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[18]  Anne J. Ridley,et al.  Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages , 2008, Journal of Cell Science.

[19]  N. Saini,et al.  MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells , 2011, Cellular and Molecular Life Sciences.

[20]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[21]  Agnieszka Bronisz,et al.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.

[22]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[23]  B. Zhou,et al.  Snail: More than EMT. , 2010, Cell adhesion & migration.

[24]  Ichiro Mori,et al.  Chromosome 3p and breast cancer , 2002, Journal of Human Genetics.

[25]  Sheng Tan,et al.  Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. , 2011, Cancer research.

[26]  O. Kent,et al.  A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells , 2009, Cancer biology & therapy.

[27]  Ivan Ovcharenko,et al.  rVISTA 2.0: evolutionary analysis of transcription factor binding sites , 2004, Nucleic Acids Res..

[28]  M. Emi,et al.  Detailed deletion mapping of chromosome arm 3p in breast cancers: A 2‐cM region on 3p14.3‐21.1 and a 5‐cM region on 3p24.3‐25.1 commonly deleted in tumors , 1997, Genes, chromosomes & cancer.

[29]  T. Zhu,et al.  Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior. , 2009, Endocrinology.

[30]  Lena Smirnova,et al.  Regulation of miRNA expression during neural cell specification , 2005, The European journal of neuroscience.

[31]  Einat Sitbon,et al.  hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. , 2010, Cancer research.

[32]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[33]  W. Ding,et al.  Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics , 2011, BMC Cancer.

[34]  L. Nelles,et al.  Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition , 2007, Oncogene.

[35]  J. Minna,et al.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. , 2001, The American journal of pathology.

[36]  F. Westermann,et al.  MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival , 2011, Cell Death and Differentiation.

[37]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[38]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[39]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[40]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[41]  H. Tsuda.  Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression , 2009, Breast cancer.

[42]  Ratnesh K Singh,et al.  Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late‐onset breast carcinoma: clinical and prognostic significance , 2008, Cancer science.

[43]  Mary Anne Wheeler,et al.  Stem , 1985 .

[44]  Giuseppe Giannini,et al.  MiR‐128 up‐regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  Luigi Naldini,et al.  Stable knockdown of microRNA in vivo by lentiviral vectors , 2009, Nature Methods.

[46]  F. Yu,et al.  Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5 , 2011, Clinical Cancer Research.

[47]  Wen-Hwa Lee,et al.  BRCA1 and BRCA2 in breast cancer , 2001, The Lancet.

[48]  B. Ljung,et al.  Deletion of two separate regions on chromosome 3p in breast cancers. , 1994, Cancer research.

[49]  Wei Liu,et al.  MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a , 2008, Journal of Molecular Medicine.

[50]  S. Memarzadeh,et al.  Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. , 2010, Cell stem cell.